We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DIS icon
1151
PUT
Walt Disney
DIS
$168B
$5.11M 0.01%
58,800
+13,900
+31% +$1.33M
TRMB icon
1152
Trimble
TRMB
$13B
$5.1M 0.01%
+100,922
New +$5.62M
VIVO
1153
DELISTED
Meridian Bioscience Inc
VIVO
$5.09M 0.01%
153,227
+46,229
+43% +$1.49M
FWRG icon
1154
First Watch Restaurant Group
FWRG
$794M
$5.09M 0.01%
376,063
-110,750
-23% -$1.69M
AON icon
1155
Aon
AON
$78.4B
$5.08M 0.01%
+16,917
New +$4.94M
ATEK.WS
1156
CALL
DELISTED
Athena Technology Acquisition Corp. II Redeemable Warrants
ATEK.WS
$5.07M 0.01%
499,998
LPLA icon
1157
LPL Financial
LPLA
$26.5B
$5.05M 0.01%
+23,363
New +$5.46M
CIBR icon
1158
First Trust NASDAQ Cybersecurity ETF
CIBR
$14B
$5.05M 0.01%
130,341
+49,764
+62% +$1.97M
ASAN icon
1159
Asana
ASAN
$1.79B
$5.04M 0.01%
+366,271
New +$6.64M
GIAC
1160
DELISTED
Gesher I Acquisition Corp. Class A Ordinary Shares
GIAC
$5.03M 0.01%
495,340
LSI
1161
DELISTED
Life Storage, Inc.
LSI
$5.03M 0.01%
51,092
+48,634
+1,979% +$5.1M
SOC icon
1162
Sable Offshore Corp
SOC
$843M
$5.03M 0.01%
500,556
-758,854
-60% -$7.58M
GFGDW
1163
CALL
DELISTED
The Growth for Good Acquisition Corporation Warrant
GFGDW
$5.01M 0.01%
499,999
VIR icon
1164
Vir Biotechnology
VIR
$1.48B
$5.01M 0.01%
197,990
-148,286
-43% -$3.63M
HPLTW
1165
CALL
DELISTED
Home Plate Acquisition Corporation Warrant
HPLTW
$5.01M 0.01%
494,997
CTO
1166
CTO Realty Growth
CTO
$744M
$5M 0.01%
273,708
+145,360
+113% +$2.79M
ALTR
1167
DELISTED
Altair Engineering Inc
ALTR
$5M 0.01%
109,980
+77,895
+243% +$3.64M
LCAHW
1168
CALL
DELISTED
Landcadia Holdings IV, Inc. Warrant
LCAHW
$4.99M 0.01%
499,997
TWLVW
1169
CALL
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$4.99M 0.01%
495,158
CLDI.WS
1170
CALL
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$4.98M 0.01%
489,998
PACX
1171
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
$4.97M 0.01%
489,798
-808,875
-62% -$8.13M
ZURA icon
1172
Zura Bio
ZURA
$511M
$4.97M 0.01%
486,402
CPAA
1173
DELISTED
Conyers Park III Acquisition Corp. Class A Common Stock
CPAA
$4.95M 0.01%
499,986
BMAC.WS
1174
CALL
DELISTED
Black Mountain Acquisition Corp. Warrants, exercisable for one share of Class A Common Stock
BMAC.WS
$4.95M 0.01%
485,754
BTM
1175
DELISTED
Bitcoin Depot
BTM
$4.94M 0.01%
69,534

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.